Cargando...
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
Neuromyelitis optica (NMO) is an autoimmune inflammatory disease of the central nervous system with preferential involvement in the optic nerve and spinal cord with a widespread spectrum of clinical features; multiple therapeutic agents have been used with different results. Recent evidence points t...
Guardado en:
| Publicado en: | J Res Med Sci |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367207/ https://ncbi.nlm.nih.gov/pubmed/28458709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-1995.200275 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|